Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/NOVARTIS-AG-9364983/news/Novartis-Tochter-Sandoz-erhalt-in-Kanada-Zulassung-fur-Biosimilar-Hyrimoz-32038324/?utm_source=whatsapp&utm_medium=social&utm_campaign=share